Brief: Biotec Pharmacon Q3 Group EBITDA Rises To NOK 0.8 Mln
Oct 24 (Reuters) - Biotec Pharmacon ASA BIOTEC.OL :
* BIOTEC PHARMACON Q3 2019 REULTS
* Q3 SALES NOK 22.5 MILLION VERSUS NOK 22.1 MILLION YEAR AGO
* Q3 GROUP DELIVERED POSITIVE EBITDA WITH NOK 0.8 MILLION
(Q3
2018: NOK 0.6 MILLION)
Source text for Eikon: ID:nObil6yBja
Further company coverage: BIOTEC.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))